Furiex Pharmaceuticals (FURX) completes enrollment in two Phase III trials of the IBS treatment...

|About: Furiex Pharmaceuticals, Inc. (FURX)|By:, SA News Editor

Furiex Pharmaceuticals (FURX) completes enrollment in two Phase III trials of the IBS treatment eluxadoline — top line results are due in Q1 2014. (PR)